7‑1‑7 bottleneck insights: Overcoming low clinical suspicion in outbreak detection
Previous posts in this series examined bottleneck trends across 500 bottlenecks from 148 outbreaks in 18 partner countries and explored solutions to resource barriers in outbreak response. In this post, we dive into low clinical suspicion––the most common detection bottleneck––and promising initiatives that make a difference. Low clinical suspicion can delay the full detection and […]
7‑1‑7 bottleneck insights: Timely laboratory confirmation
Previous posts in this series examined bottleneck trends across 500 bottlenecks from 148 outbreaks in 18 partner countries and explored solutions to resource barriers and low clinical suspicion. In this post, we dive into delays in laboratory confirmation, which can derail the outbreak response. What the data showed and why it matters Above: Bottleneck synthesis […]
7‑1‑7 bottleneck insights: Unlocking resources for rapid outbreak investigation
In a previous post, we examined data from 148 outbreaks across 18 partner countries in Africa, Southeast Asia and the Americas and the trends in bottlenecks that it reveals. Now we dive deeper into one of the top bottlenecks identified – the lack of available resources to initiate outbreak investigation – and look at solutions. […]
From 18 countries to yours: 7‑1‑7 bottleneck insights
The 7-1-7 Alliance analyzed 505 bottlenecks from 148 outbreaks in 18 partner countries in Africa, Southeast Asia and the Americas to identify global patterns in the barriers to outbreak detection, notification and response. The results show consistency among the top bottlenecks as well as disease-specific trends. This simple analysis provides an example of how countries […]